世界の非血液がん治療市場：市場規模・現状・予測

• 英文タイトル：Global Non-Hematological Cancer Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7684
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、非血液がん治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、手術、放射線療法、その他）、用途別（病院、腫瘍治療センター、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・非血液がん治療の世界市場規模
・主要企業別市場シェア
・非血液がん治療の世界市場規模：種類別（化学療法、手術、放射線療法、その他）
・非血液がん治療の世界市場規模：用途別（病院、腫瘍治療センター、外来手術センター、その他）
・非血液がん治療のアメリカ市場規模（種類別、用途別）
・非血液がん治療のヨーロッパ市場規模（種類別、用途別）
・非血液がん治療の中国市場規模（種類別、用途別）
・非血液がん治療の日本市場規模（種類別、用途別）
・非血液がん治療の東南アジア市場規模（種類別、用途別）
・非血液がん治療のインド市場規模（種類別、用途別）
・非血液がん治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・非血液がん治療の世界市場予測（2019年-2025年）
・非血液がん治療の地域別市場予測（2019年-2025年）
...

Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering from cancer, according to National Cancer Institute which come under the U.S health, the statistic published in 2016 around 1,685,210 new cancer is diagnosed and 595,690 people died due to cancer. Cancer is the second important cause of death in Europe as per the WHO Regional Office for Europe in 2012, around 3.7 million new cases of cancer occur in Europe and 1.9 million death each year. Same as for Asia Pacific and the creating the awareness is also the necessary aspect to be consider.
In 2018, the global Non-Hematological Cancer Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Non-Hematological Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Hematological Cancer Treatment development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
…

Market segment by Type, the product can be split into
Chemotherapy
Surgery
Radiation Therapy
Others

Market segment by Application, split into
Hospitals
Oncology Treatment Centre
Ambulatory Surgery Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-Hematological Cancer Treatment status, future forecast, growth opportunity, key market and key players.
To present the Non-Hematological Cancer Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-Hematological Cancer Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Surgery
1.4.4 Radiation Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-Hematological Cancer Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Oncology Treatment Centre
1.5.4 Ambulatory Surgery Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-Hematological Cancer Treatment Market Size
2.2 Non-Hematological Cancer Treatment Growth Trends by Regions
2.2.1 Non-Hematological Cancer Treatment Market Size by Regions (2014-2025)
2.2.2 Non-Hematological Cancer Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-Hematological Cancer Treatment Market Size by Manufacturers
3.1.1 Global Non-Hematological Cancer Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-Hematological Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-Hematological Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Non-Hematological Cancer Treatment Key Players Head office and Area Served
3.3 Key Players Non-Hematological Cancer Treatment Product/Solution/Service
3.4 Date of Enter into Non-Hematological Cancer Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-Hematological Cancer Treatment Market Size by Type (2014-2019)
4.2 Global Non-Hematological Cancer Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Non-Hematological Cancer Treatment Market Size (2014-2019)
5.2 Non-Hematological Cancer Treatment Key Players in United States
5.3 United States Non-Hematological Cancer Treatment Market Size by Type
5.4 United States Non-Hematological Cancer Treatment Market Size by Application

6 Europe
6.1 Europe Non-Hematological Cancer Treatment Market Size (2014-2019)
6.2 Non-Hematological Cancer Treatment Key Players in Europe
6.3 Europe Non-Hematological Cancer Treatment Market Size by Type
6.4 Europe Non-Hematological Cancer Treatment Market Size by Application

7 China
7.1 China Non-Hematological Cancer Treatment Market Size (2014-2019)
7.2 Non-Hematological Cancer Treatment Key Players in China
7.3 China Non-Hematological Cancer Treatment Market Size by Type
7.4 China Non-Hematological Cancer Treatment Market Size by Application

8 Japan
8.1 Japan Non-Hematological Cancer Treatment Market Size (2014-2019)
8.2 Non-Hematological Cancer Treatment Key Players in Japan
8.3 Japan Non-Hematological Cancer Treatment Market Size by Type
8.4 Japan Non-Hematological Cancer Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-Hematological Cancer Treatment Market Size (2014-2019)
9.2 Non-Hematological Cancer Treatment Key Players in Southeast Asia
9.3 Southeast Asia Non-Hematological Cancer Treatment Market Size by Type
9.4 Southeast Asia Non-Hematological Cancer Treatment Market Size by Application

10 India
10.1 India Non-Hematological Cancer Treatment Market Size (2014-2019)
10.2 Non-Hematological Cancer Treatment Key Players in India
10.3 India Non-Hematological Cancer Treatment Market Size by Type
10.4 India Non-Hematological Cancer Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Non-Hematological Cancer Treatment Market Size (2014-2019)
11.2 Non-Hematological Cancer Treatment Key Players in Central & South America
11.3 Central & South America Non-Hematological Cancer Treatment Market Size by Type
11.4 Central & South America Non-Hematological Cancer Treatment Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-Hematological Cancer Treatment Introduction
12.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-Hematological Cancer Treatment Introduction
12.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-Hematological Cancer Treatment Introduction
12.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-Hematological Cancer Treatment Introduction
12.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Roche
12.5.1 Roche Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-Hematological Cancer Treatment Introduction
12.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.5.5 Roche Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-Hematological Cancer Treatment Introduction
12.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Astellas Pharma
12.7.1 Astellas Pharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-Hematological Cancer Treatment Introduction
12.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2014-2019)
12.7.5 Astellas Pharma Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-Hematological Cancer Treatment Key Market Segments
Table Key Players Non-Hematological Cancer Treatment Covered
Table Global Non-Hematological Cancer Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-Hematological Cancer Treatment Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Surgery Figures
Table Key Players of Surgery
Figure Radiation Therapy Figures
Table Key Players of Radiation Therapy
Figure Others Figures
Table Key Players of Others
Table Global Non-Hematological Cancer Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Oncology Treatment Centre Case Studies
Figure Ambulatory Surgery Centers Case Studies
Figure Others Case Studies
Figure Non-Hematological Cancer Treatment Report Years Considered
Table Global Non-Hematological Cancer Treatment Market Size 2014-2025 (Million US$)
Figure Global Non-Hematological Cancer Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-Hematological Cancer Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Non-Hematological Cancer Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Non-Hematological Cancer Treatment Market Share by Regions 2014-2019
Figure Global Non-Hematological Cancer Treatment Market Share by Regions 2014-2019
Figure Global Non-Hematological Cancer Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Non-Hematological Cancer Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-Hematological Cancer Treatment Market Share by Manufacturers (2014-2019)
Figure Global Non-Hematological Cancer Treatment Market Share by Manufacturers in 2018
Table Global Non-Hematological Cancer Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-Hematological Cancer Treatment Product/Solution/Service
Table Date of Enter into Non-Hematological Cancer Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Non-Hematological Cancer Treatment Market Size Share by Type (2014-2019)
Figure Global Non-Hematological Cancer Treatment Market Size Market Share by Type (2014-2019)
Table Global Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Non-Hematological Cancer Treatment Market Size Share by Application (2014-2019)
Figure Global Non-Hematological Cancer Treatment Market Size Market Share by Application (2014-2019)
Figure Global Non-Hematological Cancer Treatment Revenue Market Share by Application in 2018
Figure United States Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table United States Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table United States Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure Europe Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table Europe Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table Europe Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure China Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table China Non-Hematological Cancer Treatment Market Size by Type (2014-20189) (Million US$)
Table China Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table China Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table China Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure Japan Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table Japan Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table Japan Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table Southeast Asia Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table Southeast Asia Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure India Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table India Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table India Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table India Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table India Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Figure Central & South America Non-Hematological Cancer Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-Hematological Cancer Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-Hematological Cancer Treatment Market Share (2018-2019)
Table Central & South America Non-Hematological Cancer Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-Hematological Cancer Treatment Market Share by Type (2014-2019)
Table Central & South America Non-Hematological Cancer Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-Hematological Cancer Treatment Market Share by Application (2014-2019)
Table Novartis Company Details
Table Novartis Revenue in Non-Hematological Cancer Treatment Business (2014-2019) (Million US$)
Figure Novartis Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Roche Company Details
Table Roche Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Roche Recent Development
Table Amgen Company Details
Table Amgen Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Amgen Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2014-2019)
Table Astellas Pharma Recent Development
Table Global Non-Hematological Cancer Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Non-Hematological Cancer Treatment Market Size Share by Regions (2019-2025)
Figure Global Non-Hematological Cancer Treatment Market Size Share by Regions in 2025
Figure United States Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-Hematological Cancer Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Non-Hematological Cancer Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Non-Hematological Cancer Treatment Market Size by Product (2019-2025)
Figure Global Non-Hematological Cancer Treatment Market Size by Product in 2025
Table Global Non-Hematological Cancer Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Non-Hematological Cancer Treatment Market Size by Application (2019-2025)
Figure Global Non-Hematological Cancer Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の転移性乳がんの治療市場：市場規模・現状・予測

Global Metastatic Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7553 2019年6月14日 96Pages
当資料は、転移性乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、生物学的標的療法、乳房手術、ホルモン療法）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...

世界の口腔がんの治療市場：市場規模・現状・予測

Global Oral Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7715 2019年6月14日 98Pages
当資料は、口腔がんの治療のグローバル市場について調査・分析したレポートで、種類別（扁平上皮がん、疣状がん、小唾液腺がん、リンパ腫）、用途別（病院と診療所、研究機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の転移性大腸がんの治療市場：市場規模・現状・予測

Global Metastatic Colorectal Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7555 2019年6月14日 95Pages
当資料は、転移性大腸がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、化学療法）、用途別（病院、診療所、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の男性の乳がんの治療市場：市場規模・現状・予測

Global Male Breast Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7498 2019年6月14日 99Pages
当資料は、男性の乳がんの治療のグローバル市場について調査・分析したレポートで、種類別（薬、化学療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界の転移性骨がんの薬物治療市場：市場規模・現状・予測

Global Metastatic Bones Cancer Medication Treatment Market Size, Status and Forecast 2019-2025
QYR9N7552 2019年6月14日 95Pages
当資料は、転移性骨がんの薬物治療のグローバル市場について調査・分析したレポートで、種類別（）、用途別（）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・転移性骨がんの薬物治療の世界市場規...

世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測

Global Non-Melanoma Skin Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7688 2019年6月14日 101Pages
当資料は、非黒色腫皮膚がんの治療のグローバル市場について調査・分析したレポートで、種類別（化学療法、放射線療法、光線力学療法）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界の副鼻腔がんの治療市場：市場規模・現状・予測

Global Paranasal Sinus Cancer Treatment Market Size, Status and Forecast 2019-2025
QYR9N7762 2019年6月14日 107Pages
当資料は、副鼻腔がんの治療のグローバル市場について調査・分析したレポートで、種類別（手術、放射線療法、化学療法）、用途別（病院と診療所、がん治療研究センター、研究所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の前立腺がんの診断と治療市場：市場規模・現状・予測

Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
QYR9N7892 2019年6月14日 105Pages
当資料は、前立腺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査（PSA）、直腸デジタル検査（DRE））、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界の胃がんの検査、治療および予防市場：市場規模・現状・予測

Global Gastric Cancer Testing, Treatment and Prevention Market Size, Status and Forecast 2019-2025
QYR9N7225 2019年6月14日 92Pages
当資料は、胃がんの検査、治療および予防のグローバル市場について調査・分析したレポートで、種類別（検査、治療、予防）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の上咽頭がん市場：市場規模・現状・予測

Global Nasopharyngeal Cancer Market Size, Status and Forecast 2019-2025
QYR9N7629 2019年6月14日 98Pages
当資料は、上咽頭がんのグローバル市場について調査・分析したレポートで、種類別（手術、放射線、化学療法）、用途別（病院、診療所、がん治療とリハビリセンター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界の転移性乳がんの治療市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…
世界の転移性骨がんの薬物治療市場：市場規模・現状・予測 Bone metastasis occurs when cancer cells spread from their original site to a bone. Nearly all types ofcancer can spread (metastasize) to the bones. But some types of cancer are particularly likely to spread to bone, including breast cancer and prostatecancerIn 2018, the global Metastatic Bones Canc…
世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…